Smoking and Lipid Profile in Pilonidal Sinus Patients

Abstract

The purpose of our study was to determine the risk factors such as lipid profile and smoking on the pathogenesis of sacrococcygeal pilonidal sinus disease (SPD). A total of 26 with SPD and 42 control patients were enrolled for this study. We retrieved data of patients comprising patient age, gender, body mass index (BMI), smoking and lipid profile. Total cholesterol (TC), triglycerides (TG), low density lipoprotein- cholesterol (LDL-C) and high density lipoprotein- cholesterol (HDL-C) were evaluated for lipid profile. Mean age and BMI of SPD and control group were 21.7±1.3 and 34.5±5.7 years (p

Keywords

• Smoking, lipid profile, sinus pilonidalis

Smoking and Lipid Profile in Pilonidal Sinus Patients

Öz

Çalışmamızda pilonidal sinus hastalığında (PSH) risk faktörü olarak sigara kullanımı ve lipid profilinin patogenezdeki rolünü araştırmayı amaçladık. Çalışmamıza PSH olan 26 ve 42 kontrol olmak üzere toplam 68 olgu alınmıştır. Tüm olguların vücut kitle indeksleri (VKİ), kan lipit seviyeleri ve sigara kullanımları araştırıldı. PSH grubu ve kontrol grubunun sırasıyla yaş ortalaması 21,7±1,3 yıl, 34,5±5,7 yıl (p<0.001), VKİ ortalaması 25,7±1,5 kg/m2, 26,0±2,5 kg/m2 (p=0,6) idi. PSH ve kontrol gruplarında sırasıyla Total-kolesterol (TK) 163,8±29,0 mg/dl, 193,6±31,0 mg/dl (p<0.001), Düşük dansiteli lipoprotein-Kolesterol (DDL-K) 103,6±28,7 mg/dl, 128,5±27,5 mg/dl (p<0.001) ve Yüksek dansiteli lipoprotein-Kolesterol (YDL-K) 41,0±9,0 mg/dl, 48,0±10,5 mg/dl p=0.006) olup, değerler arasında anlamlı fark vardı, fakat ve Trigliserid (TG) 94,3±47,9 mg/dl, 83,9±46,3 mg/dl olup, değerler arasında fark saptamadık (p=0.3). Sigara kullanımı PSH olan grupta 22/26 (%84,6), kontrol grubunda 16/42 (%38,1) olguda saptandı (p<0.001). PSH olan olgularda TK, DDL-K ve YDL-K değerlerini daha düşük, fakat sigara kullanımının daha fazla olduğunu saptadık. Pilonidal sinüs grubunda sigara kullanımının artmış olması YDL-K değerinin düşüklüğü için bir etkendir, fakat PSH olan olgularda total kolesterol değerini düşüren bir etken olup olmadığını belirlemek için daha fazla olgunun katıldığı çalışmalara ihtiyaç vardır

Anahtar Kelimeler

• Sigara, lipid profili, pilonidal sinüs

Kaynakça

1. Chintapatla S, Safarani N, Kumar S, Haboubi N. Sacrococcygeal pilonidal sinus: historical review, patho- logical insight and surgical options. Tech Coloproctol 2003; 7: 3-8.
2. Sekmen U, Kara VM, Altıntoprak F, Şenol Z. Pilonidal sinus in the army: Its incidence and risk factors. National Surg J 2010; 26: 95-8. (Turkish)
3. Akinci OF, Bozer M, Uzunköy A, Düzgün SA, Coşkun A. Incidence and aetiological factors in pilonidal sinus among Turkish soldiers. Eur J Surg 1999; 165: 339-42.
4. da Silva JH. Pilonidal cyst: cause and treatment. Dis Colon Rectum 2000: 43:1146–56.
5. Gage M. Pilonidal sinus: an explanation of its embryologic development. Arch Surg 1935; 31:175-89.
6. Davage ON. The origin of sacrococcygeal pilonidal si- nuses: based on an analysis of four hundred sixty-three cases. Am J Pathol 1954; 30:1191-205.
7. Bascom J. Pilonidal sinus: origin from follicles of hairs and results of follicle removal as treatment. Surgery 1980: 87:567–72.
8. Hull TL, Wu J. Pilonidal disease. Surg Clin North Am 2002; 82:1169-85.

9. Clothier PR. Haywood IR. The natural history of the post- natal pilonidal sinus. Ann R Coll Surg Engl 1984; 66: 201-3.
10. Klass AA. The so-called pilonidal sinus. Can Med Assoc J 1956; 75: 737-42.
11. Price ML. Griffiths WAD. Normal body hair- a review, Clin Exp Dermatol 1985; 10: 87-97.
12. Sondenaa K, Andersan E, Nesvik I, Soreide JA. Patients characteristic and symptoms in chronic pilonidal sinus disease. Int J Colorectal Dis 1995; 10: 39-42.
13. Cubukçu A, Carkman S, Gönüllü NN, Alponat A, Kayabaşi B, Eyüboğlu E. Lack of evidence that obesity is a cause of pilonidal sinus disease. Eur J Surg 2001;167:297-8.
14. Cubukçu A, Gönüllü NN, Paksoy M, Alponat A, Kuru M, Ozbay O. The role of obesity on the recurrence of pilonidal sinus disease in patients,who were treated by excision and Limberg flap transposition. Int J Colorectal Dis 2000; 15:173-5.
15. Buie LA, Curtiss RK. Pilonidal disease. Surg Clin North Am 1952; 32: 1247-59.
16. Hodge RM. Pilonidal sinus. Poston Med Surg J 1880; 103:485-6.
17. Doll D, Friederichs J, Dettmann H, et al. Time and rate of sinus formation in pilonidal sinus disease. Int J Colorectal Dis 2008; 23: 359-64.
18. Louis AB. 1890-1975: Jeep disease (pilonidal disease of mechanized warfare). Dis Colon Rectum 1982; 25:384-90.
19. Karydakis GE. New approach to the problem of pilonidal sinus. Lancet 1973; 2:1414–5.
20. Bascom J. Pilonidal sinus: origin from follicles of hairs and results of follicle removal as treatment. Surgery 1980:87:567–572.
21. Arda IS, Guney LH, Sevmis S, Hicsonmez A. High body mass index as a possible risk factor for pilonidal sinus disease in adolescents. World J Surg 2005; 29:469–71.
22. Sakr M, El-Hammadi H, Moussa M, Arafa S, Rasheed M. The effect of obesity on the results of Karydakis tech- nique for the management of chronic pilonidal sinus. Int J Colorectal Dis 2003; 18:36–9.
23. Clothier PR, Haywood IR. The natural history of the post- anal pilonidal sinus. Ann R Coll Surg Engl 1984; 66: 201-3.
24. Can MF, Sevinc MM, Yilmaz M. Comparison of Karydakis flap reconstruction versus primary midline closure in sacrococcygeal pilonidal disease: results of 200 military service members. Surg Today 2009; 39:580–6.
25. Bain, C. & Jesse M.J. Cigarette consumption and deaths from coronary artery disease. Lancet 1978; 1:1087-8.
26. Martin M.J, Hulley S.B. Serum Cholesterol, B.P & mortal- ity. Lancet; 1986; 2:933-36.